GlobalData's OpportunityAnalyzer reports have been developed to provide a framework analysis for disease areas with less robust markets, but which are high-interest areas and/or have very active research pipelines.

Request a demo

The reports provide in-depth analysis of the pipeline and R&D strategies, including a comparative assessment of product candidates and discussion of trends in R&D.

Reports include:

  • Disease overview
  • Epidemiology forecasts
  • Current treatment options
  • Unmet needs assessment
  • R&D strategies
  • Pipeline assessment
  • Pipeline valuation – each drug is scored on clinical vs. commercial attributes
  • Interactive Excel deliverable

Why choose OpportunityAnalyzer reports?

The report series provides value to you for diseases where drug-level forecasts are not feasible by identifying treatable patient pool, determining the clinical and commercial viability of compounds, and enhancing understanding of the R&D strategies being employed by developers.

Who can OpportunityAnalyzer reports help?

  • Professional services
  • Investment banks and VCs
  • Contract research organizations (CROs)

© GlobalData 2017. John Carpenter House, 7 Carmelite Street, London EC4 0BS.